There is an urgent need to develop new methods for male contraception, however a major barrier to drug discovery 25 has been the lack of validated targets and the absence of an effective high-throughput phenotypic screening system. To 26 address this deficit, we developed a fully-automated robotic screening platform that provided quantitative evaluation 27 of compound activity against two key attributes of human sperm function: motility and acrosome reaction. In order to 28 accelerate contraceptive development, we screened the comprehensive collection of 12,000 molecules that make up 29 the ReFRAME repurposing library, comprising nearly all the small molecules that have been approved or have undergone 30 clinical development, or have significant preclinical profiling. We identified several compounds that potently inhibit 31 motility representing either novel drug candidates or routes to target identification. This platform will now allow for 32 major drug discovery programmes that address the critical gap in the contraceptive portfolio as well as uncover novel 33 human sperm biology. 34 35 36 Introduction.
systems (Supplementary
) and a comparable distribution was observed between experimental days, plates and 81 positions ( Supplementary Figure 1.1 A) with any small differences between days stemming from donor pool variance.
82
Importantly, spermatozoa were found to be tolerant to DMSO (~4%), far above typical screening concentration of 0.1% 83 (Supplementary Figure 1C) . To determine the optimal screening batch size spermatozoa were dispensed every 30 84 minutes for 150 minutes observing only a small decrease in motility (~10%) after 4 plates were screened (Supplementary 85 Figure 1D ). A flow cytometry-based assay measuring AR ( Figure 1D ) was run directly afterwards ( Figure 1E , F & 86 Supplementary Figure 1E ).
88
Screening of the ReFRAME library, confirmation of hits by dose response.
89
The ReFRAME library (11,968 compounds) was supplied in "assay-ready" imaging plates and was solubilised prior to 90 addition of sperm. A total of 63 compounds decreased motility (Figure 2 A, B with examples in Figure 2C , E and 91 supplementary movies 1 & 2). High assay quality was achieved throughout with a Z'-factor between 0.4-0.8 ( Figure 2D ). Table 1 ). Amongst the confirmed hits were the aldehyde dehydrogenase inhibitor, Disulfiram (70% maximum reduction 96 at 10 µM) and a putative platelet aggregation inhibitor, KF-4939 (100% max. reduction; EC50=0.49µM), and a range of 97 other compounds having very modest effect and/or showing low potency (See Supplementary Figure 2 , Supplementary 98 Table 1 ). In the AR screen, 9 of the resupplied compounds had a dose-dependent effect with EC50 values as low as 0.4 99 µM (See Supplementary Figure 3 , Supplementary Table 2 ). However, following the orthogonal assay triaging none of Gruber et al., 10 th October 2019 SHORT REPORT 6 141 Moreover, the Toll-like receptor 7/8 ligand (Resquimod; R848) recently shown to preferentially reduce the motility of X 142 chromosome-bearing mouse sperm by suppressing ATP production (Umehara et al, 2019) was a hit in our screen, 143 demonstrating that this phenotypic screening approach has the potential to uncover new aspects of sperm biology.
145
In summary, our high-throughput phenotypic platform allows for the screening of bioactives including natural products, 146 focussed small molecule libraries and chemical diversity sets, which can provide novel start-points for male 147 contraceptive drug development. 
157
A pre-existing automated cell-based phenotypic screening platform was adapted that utilises a Yokogawa CV7000 Cell 158 Voyager high-throughput microscope able to image 384 multiwell plates under full environmental control at high speed.
159
For high throughput screening with human spermatozoa to be effective and yield meaningful hits, the system needed 160 to replicate, as close as possible, the manual workflow currently used in an andrology lab, so that the effect of large 161 numbers of compounds on viable human sperm could be performed. In order to achieve this goal, we investigated a 162 number of factors that could impact the quality of the data such as: plate type; concentration and number of 163 spermatozoa per well; logistics of spermatozoa preparation and handling; dispense speed for getting spermatozoa into 164 384 well plates; timing of compound addition; temperature control; image acquisition parameters; algorithm choice for 165 motility assessment and data management and, evaluating the overall speed of data analysis. A flow cytometry-based 166 assay and data analysis workflow was developed to measure acrosomal status. The goal was to be able to screen a 384-167 well plate in both assays consecutively within 90 minutes of sperm dispensing using a fully automatic robotic system.
168
Data was analysed for inter-and intra-plate variation (both technical and biological replicates) and signal-to-background 169 and variance measured to demonstrate the assay was reproducible and robust. The assay was shown to be scalable 170 and all the workflows optimal. Once established, the system was validated by screening the ReFRAME library (Janes et 171 al., 2018) and hits confirmed by dose-response analysis.
173

Sperm handling
174
Control semen samples were obtained from volunteer donors with normal sperm concentration, motility and semen 175 characteristics (WHO, 2010) and no known fertility problems. Samples were obtained by masturbation after 48-72 h of 176 sexual abstinence. After ~30 min of liquefaction at 37°C, cells were prepared using a discontinuous density gradient Inc.) and maintained at 37°C with gentle stirring (100 rpm) in a water bath on top of a magnetic stirrer. Approximately 186 10,000 spermatozoa were dispensed per well using a MultiDrop Combi (ThermoFisher) into pre-warmed assay-ready 187 plates. Spermatozoa were incubated with the compounds for 10 mins (thus favouring fast acting compounds) at 37°C 188 in the CV7000 microscope prior to the commencement of imaging. 
198
A Python implementation of the particle tracking algorithm originally developed by others (Crocker and Grier, 1996) , 1987) and general sperm viability (using propidium iodide, Pi). This assay was run 208 directly after motility assessment. Controls (DMSO and the Ca 2+ ionophore A23187) were added using an acoustic 209 dispenser (Echo 555, Labcyte Inc.) and incubated for 10 minutes at 37°C in the SteriStore (HighRes Biosolutions Inc.).
210
PNA488 (ThermoFisher Scientific, Cat. No. L21409, stored as 1 mg/mL stock) was then added to achieve a 1:1000 final 211 dilution and propidium iodide (ThermoFisher Scientific, Live/Dead Sperm Viability kit, Cat. No. L7011, stored as 2.4 mM 212 solution) was added to achieve a 1:2000 final dilution using a liquid handler (Tempest, Formulatrix). After addition of 213 dyes, plates were incubated for 10 minutes at 37°C in the SteriStore before sampling using an iQue Screener (2 sec sip 
236
15% reduction of VCL. VCL was chosen as the main kinetic measurement as it had an acceptable Z' value and is 237 independent of path averaging. Wells with autofocus errors or compounds which did not dissolve properly (resulting in 238 sperm cells being stuck in one location but moving normally in the rest of the well) were excluded from analysis.
All experiments were performed with pools of donors (3-5 per batch of 4 screening plates) and results normalised to 259 DMSO-treated wells (16 wells per plate).
261
The ReFrame library has been screened for cytotox (using CellTiterGlo) in HEK293 and HepG2 cells (see 262 www.reframedb.org) with some of the hit compounds displaying activity in one or both assays (Supplementary Figure   263 2), information which helps inform compound progression decisions.
265
Dose response experiments 266
Assay-ready 384-well CellCarrier plates with 8-point curves (10 µM highest concentration) were resupplied by CALIBR 267 in duplicate and processed as described above. Curves were fitted using the R package dr4pl (https://cran.r-268 project.org/web/packages/dr4pl/index.html) using a 4-parameter logistic fit option.
270
Triaging of AR hits.
271
Given the prevalence of a range of interfering compounds amongst the library hits, two approaches were used for 272 triaging. These additional triaging steps, after the primary screen, allowed for the elimination of intrinsically fluorescent 
